ITPA gene variants protect against anaemia in patients treated for chronic hepatitis C

被引:377
作者
Fellay, Jacques [1 ]
Thompson, Alexander J. [2 ,3 ]
Ge, Dongliang [1 ]
Gumbs, Curtis E. [1 ]
Urban, Thomas J. [1 ]
Shianna, Kevin V. [1 ]
Little, Latasha D. [1 ]
Qiu, Ping [4 ]
Bertelsen, Arthur H. [4 ]
Watson, Mark [4 ]
Warner, Amelia [4 ]
Muir, Andrew J. [2 ,3 ]
Brass, Clifford [4 ]
Albrecht, Janice [4 ]
Sulkowski, Mark [5 ]
McHutchison, John G. [2 ,3 ]
Goldstein, David B. [1 ]
机构
[1] Duke Univ, Ctr Human Genome Variat, Inst Genome Sci & Policy, Durham, NC 27708 USA
[2] Duke Univ, Div Gastroenterol, Sch Med, Div Gastroenterol, Durham, NC 27705 USA
[3] Duke Univ, Duke Clin Res Inst, Durham, NC 27705 USA
[4] Schering Plough Res Inst, Kenilworth, NJ 07033 USA
[5] Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA
基金
英国医学研究理事会;
关键词
TRIPHOSPHATE PYROPHOSPHOHYDROLASE DEFICIENCY; NONSPHEROCYTIC HEMOLYTIC-ANEMIA; WHOLE-GENOME ASSOCIATION; INOSINE TRIPHOSPHATASE; HEXOKINASE DEFICIENCY; MISSENSE MUTATION; POPULATION; PHENOTYPE; RIBAVIRIN;
D O I
10.1038/nature08825
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Chronic infection with the hepatitis C virus (HCV) affects 170 million people worldwide and is an important cause of liver-related morbidity and mortality(1). The standard of care therapy combines pegylated interferon (pegIFN) alpha and ribavirin (RBV), and is associated with a range of treatment-limiting adverse effects(2). One of the most important of these is RBV-induced haemolytic anaemia, which affects most patients and is severe enough to require dose modification in up to 15% of patients. Here we show that genetic variants leading to inosine triphosphatase deficiency, a condition not thought to be clinically important, protect against haemolytic anaemia in hepatitis-C-infected patients receiving RBV.
引用
收藏
页码:405 / 408
页数:4
相关论文
共 27 条
[1]   A haplotype map of the human genome [J].
Altshuler, D ;
Brooks, LD ;
Chakravarti, A ;
Collins, FS ;
Daly, MJ ;
Donnelly, P ;
Gibbs, RA ;
Belmont, JW ;
Boudreau, A ;
Leal, SM ;
Hardenbol, P ;
Pasternak, S ;
Wheeler, DA ;
Willis, TD ;
Yu, FL ;
Yang, HM ;
Zeng, CQ ;
Gao, Y ;
Hu, HR ;
Hu, WT ;
Li, CH ;
Lin, W ;
Liu, SQ ;
Pan, H ;
Tang, XL ;
Wang, J ;
Wang, W ;
Yu, J ;
Zhang, B ;
Zhang, QR ;
Zhao, HB ;
Zhao, H ;
Zhou, J ;
Gabriel, SB ;
Barry, R ;
Blumenstiel, B ;
Camargo, A ;
Defelice, M ;
Faggart, M ;
Goyette, M ;
Gupta, S ;
Moore, J ;
Nguyen, H ;
Onofrio, RC ;
Parkin, M ;
Roy, J ;
Stahl, E ;
Winchester, E ;
Ziaugra, L ;
Shen, Y .
NATURE, 2005, 437 (7063) :1299-1320
[2]   The ITPA c.94C>A and g.IVS2+21A>C sequence variants contribute to missplicing of the ITPA gene [J].
Arenas, Monica ;
Duley, John ;
Sumi, Satoshi ;
Sanderson, Jeremy ;
Marinaki, Anthony .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2007, 1772 (01) :96-102
[3]   Analysis of ITPA phenotype-genotype correlation in the Bulgarian population revealed a novel gene variant in Exon 6 [J].
Atanasova, Srebrena ;
Shipkova, Maria ;
Svinarov, Dobrin ;
Mladenova, Antoaneta ;
Genova, Mariana ;
Wieland, Eberhard ;
Oellerich, Michael ;
von Ahsen, Nicolas .
THERAPEUTIC DRUG MONITORING, 2007, 29 (01) :6-10
[4]   Pharmacogenetic significance of inosine triphosphatase [J].
Bierau, Jorgen ;
Lindhout, Martijn ;
Bakker, Jaap A. .
PHARMACOGENOMICS, 2007, 8 (09) :1221-1228
[5]   Genetic Variant m HK1 Is Associated With a Proanemic State and A1C but Not Other Glycemic Control-Related Traits [J].
Bonnefond, Amelie ;
Vaxillaire, Martine ;
Labrune, Yann ;
Lecoeur, Cecile ;
Chevre, Jean-Claude ;
Bouatia-Naji, Nabila ;
Cauchi, Stephane ;
Balkau, Beverley ;
Marre, Michel ;
Tichet, Jean ;
Riveline, Jean-Pierre ;
Hadjadj, Samy ;
Gallois, Yves ;
Czernichow, Sebastien ;
Hercberg, Serge ;
Kaakinen, Marika ;
Wiesner, Susanne ;
Charpentier, Guillaume ;
Levy-Marchal, Claire ;
Elliott, Paul ;
Jarvelin, Marjo-Riitta ;
Horber, Fritz ;
Dina, Christian ;
Pedersen, Oluf ;
Sladek, Robert ;
Meyre, David ;
Froguel, Philippe .
DIABETES, 2009, 58 (11) :2687-2697
[6]   DNA polymorphisms in ITPA including basis of inosine triphosphatase deficiency [J].
Cao, HN ;
Hegele, RA .
JOURNAL OF HUMAN GENETICS, 2002, 47 (11) :620-622
[7]   First mutation in the red blood cell-specific promoter of hexokinase combined with a novel missense mutation causes hexokinase deficiency and mild chronic hemolysis [J].
de Vooght, Karen M. K. ;
van Solinge, Wouter W. ;
van Wesel, Annet C. ;
Kersting, Sabina ;
van Wijk, Richard .
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 (09) :1203-1210
[8]   Rare Variants Create Synthetic Genome-Wide Associations [J].
Dickson, Samuel P. ;
Wang, Kai ;
Krantz, Ian ;
Hakonarson, Hakon ;
Goldstein, David B. .
PLOS BIOLOGY, 2010, 8 (01)
[9]   INDIVIDUAL VARIATION IN INOSINE TRIPHOSPHATE ACCUMULATION IN HUMAN ERYTHROCYTES [J].
FRASER, JH ;
MEYERS, H ;
HENDERSON, JF ;
BROX, LW ;
MCCOY, EE .
CLINICAL BIOCHEMISTRY, 1975, 8 (06) :353-364
[10]   Multiple loci influence erythrocyte phenotypes in the CHARGE Consortium [J].
Ganesh, Santhi K. ;
Zakai, Neil A. ;
van Rooij, Frank J. A. ;
Soranzo, Nicole ;
Smith, Albert V. ;
Nalls, Michael A. ;
Chen, Ming-Huei ;
Kottgen, Anna ;
Glazer, Nicole L. ;
Dehghan, Abbas ;
Kuhnel, Brigitte ;
Aspelund, Thor ;
Yang, Qiong ;
Tanaka, Toshiko ;
Jaffe, Andrew ;
Bis, Joshua C. M. ;
Verwoert, Germaine C. ;
Teumer, Alexander ;
Fox, Caroline S. ;
Guralnik, Jack M. ;
Ehret, Georg B. ;
Rice, Kenneth ;
Felix, Janine F. ;
Rendon, Augusto ;
Eiriksdottir, Gudny ;
Levy, Daniel ;
Patel, Kushang V. ;
Boerwinkle, Eric ;
Rotter, Jerome I. ;
Hofman, Albert ;
Sambrook, Jennifer G. ;
Hernandez, Dena G. ;
Zheng, Gang ;
Bandinelli, Stefania ;
Singleton, Andrew B. ;
Coresh, Josef ;
Lumley, Thomas ;
Uitterlinden, Andre G. ;
vanGils, Janine M. ;
Launer, Lenore J. ;
Cupples, L. Adrienne ;
Oostra, Ben A. ;
Zwaginga, Jaap-Jan ;
Ouwehand, Willem H. ;
Thein, Swee-Lay ;
Meisinger, Christa ;
Deloukas, Panos ;
Nauck, Matthias ;
Spector, Tim D. ;
Gieger, Christian .
NATURE GENETICS, 2009, 41 (11) :1191-U48